Narla J, Mohandas N
Regional Medical Center, San Jose, CA, USA.
New York Blood Center, New York, NY, USA.
Int J Lab Hematol. 2017 May;39 Suppl 1:47-52. doi: 10.1111/ijlh.12657.
Significant advances have been made in our understanding of the structural basis for altered cell function in various inherited red cell membrane disorders with reduced red cell survival and resulting hemolytic anemia. The current review summarizes these advances as they relate to defining the molecular and structural basis for disorders involving altered membrane structural organization (hereditary spherocytosis [HS] and hereditary elliptocytosis [HE]) and altered membrane transport function (hereditary overhydrated stomatocytosis and hereditary xerocytosis). Mutations in genes encoding membrane proteins that account for these distinct red cell phenotypes have been identified. These molecular insights have led to improved understanding of the structural basis for altered membrane function in these disorders. Weakening of vertical linkage between the lipid bilayer and spectrin-based membrane skeleton leads to membrane loss in HS. In contrast, weakening of lateral linkages among different skeletal proteins leads to membrane fragmentation and decreased surface area in HE. The degrees of membrane loss and resultant increases in cell sphericity determine the severity of anemia in these two disorders. Splenectomy leads to amelioration of anemia by increasing the circulatory red cell life span of spherocytic red cells that are normally sequestered by the spleen. Disordered membrane cation permeability and resultant increase or decrease in red cell volume account for altered cellular deformability of hereditary overhydrated stomatocytosis and hereditary xerocytosis, respectively. Importantly, splenectomy is not beneficial in these two membrane transport disorders and in fact contraindicated due to severe postsplenectomy thrombotic complications.
在我们对各种遗传性红细胞膜疾病中细胞功能改变的结构基础的理解方面已经取得了重大进展,这些疾病会导致红细胞存活时间缩短并引发溶血性贫血。本综述总结了这些进展,这些进展与确定涉及膜结构组织改变(遗传性球形红细胞增多症[HS]和遗传性椭圆形红细胞增多症[HE])以及膜转运功能改变(遗传性水肿性口形红细胞增多症和遗传性干瘪红细胞增多症)的疾病的分子和结构基础有关。已经确定了编码导致这些不同红细胞表型的膜蛋白的基因突变。这些分子见解有助于更好地理解这些疾病中膜功能改变的结构基础。脂质双层与血影蛋白基膜骨架之间垂直连接的减弱导致HS中的膜丢失。相比之下,不同骨架蛋白之间横向连接的减弱导致膜碎片化和HE中表面积减小。膜丢失的程度以及由此导致的细胞球形度增加决定了这两种疾病中贫血的严重程度。脾切除术通过增加通常被脾脏扣留的球形红细胞的循环红细胞寿命来改善贫血。遗传性水肿性口形红细胞增多症和遗传性干瘪红细胞增多症的细胞变形性改变分别是由于膜阳离子通透性紊乱以及由此导致的红细胞体积增加或减少所致。重要的是,脾切除术对这两种膜转运疾病无益,实际上由于严重的脾切除术后血栓形成并发症而被禁忌。